U.S. flag

An official website of the United States government

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 4

1.
Figure 1

Figure 1. From: Pathology of rituximab-induced Kaposi sarcoma flare.

Cutaneous Kaposi sarcoma lesion, plaque stage (H&E stain; original magnification ×100).

Liron Pantanowitz, et al. BMC Clin Pathol. 2008;8:7-7.

CitationFull text

2.
Figure 3

Figure 3. From: Pathology of rituximab-induced Kaposi sarcoma flare.

K5 immunoreactivity is shown in occasional tumor cells (arrows) in this KS flare lesion (K5 immunohistochemical stain; original magnification ×400).

Liron Pantanowitz, et al. BMC Clin Pathol. 2008;8:7-7.

CitationFull text

3.
Figure 4

Figure 4. From: Pathology of rituximab-induced Kaposi sarcoma flare.

Comparison of the inflammatory component between control (left) and KS flare (right) specimens. Both lesions exhibit admixed T-cells (CD3), whereas only the KS flare tumor has a complete absence of B-cells (CD20).

Liron Pantanowitz, et al. BMC Clin Pathol. 2008;8:7-7.

CitationFull text

4.
Figure 2

Figure 2. From: Pathology of rituximab-induced Kaposi sarcoma flare.

Higher power magnification of Kaposi sarcoma lesion showing infiltrating plump spindled tumor cells admixed with blood vessels and a sparse mononuclear inflammatory infiltrate (H&E stain; original magnification ×400).

Liron Pantanowitz, et al. BMC Clin Pathol. 2008;8:7-7.

CitationFull text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center